Literature DB >> 22875636

Does structural neuroimaging reveal a disturbance of iron metabolism in Parkinson's disease? Implications from MRI and TCS studies.

Adriane Gröger1, Daniela Berg.   

Abstract

A central role of iron in the pathogenesis of Parkinson's disease (PD) has been discussed for many years. Numerous studies using magnetic resonance imaging and transcranial sonography have been performed to detect alterations in tissue iron content of the substantia nigra. This manuscript reviews the findings of this still controversial issue and indicates that specific abnormalities that are suggested to be related to a disturbance of iron homeostasis may play an early role in the pathogenesis of PD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22875636     DOI: 10.1007/s00702-012-0873-0

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  51 in total

1.  Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence.

Authors:  J M Graham; M N Paley; R A Grünewald; N Hoggard; P D Griffiths
Journal:  Brain       Date:  2000-12       Impact factor: 13.501

2.  High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson's disease.

Authors:  Ashley K Lotfipour; Samuel Wharton; Stefan T Schwarz; V Gontu; Andreas Schäfer; Andrew M Peters; Richard W Bowtell; Dorothee P Auer; Penny A Gowland; Nin P S Bajaj
Journal:  J Magn Reson Imaging       Date:  2011-10-10       Impact factor: 4.813

Review 3.  Imaging iron stores in the brain using magnetic resonance imaging.

Authors:  E Mark Haacke; Norman Y C Cheng; Michael J House; Qiang Liu; Jaladhar Neelavalli; Robert J Ogg; Asadullah Khan; Muhammad Ayaz; Wolff Kirsch; Andre Obenaus
Journal:  Magn Reson Imaging       Date:  2005-01       Impact factor: 2.546

4.  The relation between brain iron and NMR relaxation times: an in vitro study.

Authors:  J Vymazal; R A Brooks; C Baumgarner; V Tran; D Katz; J W Bulte; R Bauminger; G Di Chiro
Journal:  Magn Reson Med       Date:  1996-01       Impact factor: 4.668

5.  Different iron-deposition patterns of multiple system atrophy with predominant parkinsonism and idiopathetic Parkinson diseases demonstrated by phase-corrected susceptibility-weighted imaging.

Authors:  Y Wang; S R Butros; X Shuai; Y Dai; C Chen; M Liu; E M Haacke; J Hu; H Xu
Journal:  AJNR Am J Neuroradiol       Date:  2011-11-03       Impact factor: 3.825

6.  Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 Tesla.

Authors:  R J Ordidge; J M Gorell; J C Deniau; R A Knight; J A Helpern
Journal:  Magn Reson Med       Date:  1994-09       Impact factor: 4.668

7.  Determination of brain iron content in patients with Parkinson's disease using magnetic susceptibility imaging.

Authors:  Wei Zhang; Sheng-Gan Sun; Yu-Hong Jiang; Xian Qiao; Xin Sun; Yan Wu
Journal:  Neurosci Bull       Date:  2009-12       Impact factor: 5.203

8.  Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain.

Authors:  E Sofic; P Riederer; H Heinsen; H Beckmann; G P Reynolds; G Hebenstreit; M B Youdim
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

9.  MRI assessment of basal ganglia iron deposition in Parkinson's disease.

Authors:  Lauren I Wallis; Martyn N J Paley; Jacqueline M Graham; Richard A Grünewald; Emma L Wignall; Harriet M Joy; Paul D Griffiths
Journal:  J Magn Reson Imaging       Date:  2008-11       Impact factor: 4.813

10.  The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study.

Authors:  Alexandra Gaenslen; Barbara Unmuth; Jana Godau; Inga Liepelt; Adriana Di Santo; Katherine Johanna Schweitzer; Thomas Gasser; Hans-Jürgen Machulla; Matthias Reimold; Kenneth Marek; Daniela Berg
Journal:  Lancet Neurol       Date:  2008-04-03       Impact factor: 44.182

View more
  12 in total

1.  Signal Alteration of Substantia Nigra on 3.0T Susceptibility-weighted Imaging in Parkinson's Disease and Vascular Parkinsonism.

Authors:  Xue-Jun Zhao; Xi-Yuan Niu; He-Yang You; Min Zhou; Xue-Bing Ji; Ying Liu; Lei Wu; Xiao-Ling Ding
Journal:  Curr Med Sci       Date:  2019-10-14

Review 2.  The role of iron in brain ageing and neurodegenerative disorders.

Authors:  Roberta J Ward; Fabio A Zucca; Jeff H Duyn; Robert R Crichton; Luigi Zecca
Journal:  Lancet Neurol       Date:  2014-10       Impact factor: 44.182

3.  Liver-Specific, but Not Retina-Specific, Hepcidin Knockout Causes Retinal Iron Accumulation and Degeneration.

Authors:  Bailey H Baumann; Wanting Shu; Ying Song; Jacob Sterling; Zbynek Kozmik; Samira Lakhal-Littleton; Joshua L Dunaief
Journal:  Am J Pathol       Date:  2019-07-06       Impact factor: 4.307

4.  Targeting chelatable iron as a therapeutic modality in Parkinson's disease.

Authors:  David Devos; Caroline Moreau; Jean Christophe Devedjian; Jérome Kluza; Maud Petrault; Charlotte Laloux; Aurélie Jonneaux; Gilles Ryckewaert; Guillaume Garçon; Nathalie Rouaix; Alain Duhamel; Patrice Jissendi; Kathy Dujardin; Florent Auger; Laura Ravasi; Lucie Hopes; Guillaume Grolez; Wance Firdaus; Bernard Sablonnière; Isabelle Strubi-Vuillaume; Noel Zahr; Alain Destée; Jean-Christophe Corvol; Dominik Pöltl; Marcel Leist; Christian Rose; Luc Defebvre; Philippe Marchetti; Z Ioav Cabantchik; Régis Bordet
Journal:  Antioxid Redox Signal       Date:  2014-02-06       Impact factor: 8.401

Review 5.  Iron metabolism in the CNS: implications for neurodegenerative diseases.

Authors:  Tracey A Rouault
Journal:  Nat Rev Neurosci       Date:  2013-07-03       Impact factor: 34.870

6.  Ginsenoside Rg1 Plays a Neuroprotective Role in Regulating the Iron-Regulated Proteins and Against Lipid Peroxidation in Oligodendrocytes.

Authors:  Ying Chen; Yan-Yan Li; Shuo Wang; Tiantian Zhou; Nai-Hong Chen; Yu-He Yuan
Journal:  Neurochem Res       Date:  2022-02-28       Impact factor: 3.996

Review 7.  Lactoferrin: from the structure to the functional orchestration of iron homeostasis.

Authors:  Giusi Ianiro; Luigi Rosa; Maria Carmela Bonaccorsi di Patti; Piera Valenti; Giovanni Musci; Antimo Cutone
Journal:  Biometals       Date:  2022-10-10       Impact factor: 3.378

8.  Serum uric acid and nigral iron deposition in Parkinson's disease: a pilot study.

Authors:  Tae-Hyoung Kim; Jae-Hyeok Lee
Journal:  PLoS One       Date:  2014-11-11       Impact factor: 3.240

9.  Shifted dynamic interactions between subcortical nuclei and inferior frontal gyri during response preparation in persistent developmental stuttering.

Authors:  F Luise Metzger; Tibor Auer; Gunther Helms; Walter Paulus; Jens Frahm; Martin Sommer; Nicole E Neef
Journal:  Brain Struct Funct       Date:  2017-07-24       Impact factor: 3.270

Review 10.  Bioavailable Trace Metals in Neurological Diseases.

Authors:  Aurélia Poujois; Jean-Christophe Devedjian; Caroline Moreau; David Devos; Pascal Chaine; France Woimant; James A Duce
Journal:  Curr Treat Options Neurol       Date:  2016-10       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.